Skip to content

Clinical trials

Phase 3 Retinal Vein Occlusion trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Phase: Phase 3 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20091
20101
20111
20121
20141
20171
20181
20192
20202
20215

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan2
Clearside Biomedical, Inc.2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Outlook Therapeutics, Inc.2
Regeneron Pharmaceuticals2
The Emmes Company, LLC2
AbbVie1
Kodiak Sciences Inc1
National Eye Institute (NEI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion20
Macular Edema14
Vision Disorders3
Macular Degeneration2
Wet Macular Degeneration2
Eye Diseases1
Glaucoma, Angle-Closure1
Retinal Degeneration1
Retinal Diseases1
Vision, Low1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.